• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

中国老年人流感及疫苗接种建议。

Recommendations for influenza and vaccination in elderly people in China.

作者信息

Chen Qiong, Wang Lijing, Xie Mingxuan, Li Xiaoying

机构信息

Department of Geriatrics Department of Respiratory Medicine Xiangya Hospital Central South University Changsha China.

National Clinical Research Center for Geriatric Disorders Xiangya Hospital Central South University Changsha China.

出版信息

Aging Med (Milton). 2020 Mar 18;3(1):1-11. doi: 10.1002/agm2.12102. eCollection 2020 Mar.

DOI:10.1002/agm2.12102
PMID:32232186
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC7099755/
Abstract

Influenza and pneumonia can be prevented by vaccination, but they remain major causes of morbidity and mortality in age-related diseases. In most areas of China, the rates of influenza and pneumococcal vaccination are relatively low and public awareness of vaccination remains insufficient. Thus, it is essential to recommend influenza and vaccination to elderly people in clinical practice. Based on recently published studies and related documents issued by several vaccination authorities, such as the World Health Organization, the National Health and Wellness Committee, the Chinese Center for Disease Control and Prevention, the US Centers for Disease Control and Prevention, and the US Advisory Committee on Immunization Practices, we propose official recommendations for influenza and vaccination in elderly people in China.

摘要

流感和肺炎可通过接种疫苗预防,但它们仍是与年龄相关疾病中发病和死亡的主要原因。在中国大部分地区,流感和肺炎球菌疫苗接种率相对较低,公众对疫苗接种的意识仍然不足。因此,在临床实践中向老年人推荐流感和肺炎球菌疫苗接种至关重要。基于世界卫生组织、国家卫生健康委、中国疾病预防控制中心、美国疾病控制与预防中心以及美国免疫实践咨询委员会等多个疫苗接种权威机构最近发表的研究和相关文件,我们提出针对中国老年人流感和肺炎球菌疫苗接种的官方建议。

相似文献

1
Recommendations for influenza and vaccination in elderly people in China.中国老年人流感及疫苗接种建议。
Aging Med (Milton). 2020 Mar 18;3(1):1-11. doi: 10.1002/agm2.12102. eCollection 2020 Mar.
2
[Technical guidelines for seasonal influenza vaccination in China (2020-2021)].《中国季节性流感疫苗接种技术指南(2020—2021年)》
Zhonghua Yu Fang Yi Xue Za Zhi. 2020 Oct 6;54(10):1035-1059. doi: 10.3760/cma.j.cn112150-20200911-01198.
3
[Technical guidelines for seasonal influenza vaccination in China (2021-2022)].《中国季节性流感疫苗接种技术指南(2021—2022年)》
Zhonghua Liu Xing Bing Xue Za Zhi. 2021 Oct 10;42(10):1722-1749. doi: 10.3760/cma.j.cn112338-20210913-00732.
4
[Technical guidelines for seasonal influenza vaccination in China (2020-2021)].《中国季节性流感疫苗接种技术指南(2020—2021年)》
Zhonghua Liu Xing Bing Xue Za Zhi. 2020 Oct 10;41(10):1555-1576. doi: 10.3760/cma.j.cn112338-20200904-01126.
5
[Technical guidelines for seasonal influenza vaccination in China (2023-2024)].《中国季节性流感疫苗接种技术指南(2023—2024年)》
Zhonghua Liu Xing Bing Xue Za Zhi. 2023 Oct 10;44(10):1507-1530. doi: 10.3760/cma.j.cn112338-20230908-00139.
6
[Technical guidelines for seasonal influenza vaccination in China (2019-2020)].《中国季节性流感疫苗接种技术指南(2019—2020年)》
Zhonghua Yu Fang Yi Xue Za Zhi. 2020 Jan 6;54(1):21-36. doi: 10.3760/cma.j.issn.0253-9624.2020.01.007.
7
[Technical guidelines for seasonal influenza vaccination in China (2022-2023)].《中国季节性流感疫苗接种技术指南(2022—2023年)》
Zhonghua Liu Xing Bing Xue Za Zhi. 2022 Oct 10;43(10):1515-1544. doi: 10.3760/cma.j.cn112338-20220825-00734.
8
[Technical guidelines for seasonal influenza vaccination in China (2022-2023)].《中国季节性流感疫苗接种技术指南(2022—2023年)》
Zhonghua Yu Fang Yi Xue Za Zhi. 2022 Oct 6;56(10):1356-1386. doi: 10.3760/cma.j.cn112150-20220825-00840.
9
A Simple Approach to Pneumococcal Vaccination in Adults.成人肺炎球菌疫苗接种的简易方法
J Glob Infect Dis. 2018 Jul-Sep;10(3):159-162. doi: 10.4103/jgid.jgid_88_17.
10
Factors associated with pneumococcal vaccination among an urban elderly population in China.中国城市老年人群中与肺炎球菌疫苗接种相关的因素。
Hum Vaccin Immunother. 2014;10(10):2994-9. doi: 10.4161/21645515.2014.972155.

引用本文的文献

1
Using the COM-B model to explore factors influencing influenza vaccination among the elderly: Insights from primary healthcare workers in China.运用COM-B模型探究影响老年人流感疫苗接种的因素:来自中国基层医护人员的见解
Hum Vaccin Immunother. 2025 Dec;21(1):2550859. doi: 10.1080/21645515.2025.2550859. Epub 2025 Aug 26.
2
Determinants of pneumococcal vaccination behavior among elderly people aged ≥60 years in Jiangxi, China.中国江西省60岁及以上老年人肺炎球菌疫苗接种行为的影响因素
Medicine (Baltimore). 2025 May 30;104(22):e42597. doi: 10.1097/MD.0000000000042597.
3
Adverse events affecting recovery from seasonal influenza vaccination in the hypertensive population: A population-based pharmacovigilance analysis.影响高血压人群季节性流感疫苗接种后恢复的不良事件:一项基于人群的药物警戒分析。
PLoS One. 2025 May 20;20(5):e0310474. doi: 10.1371/journal.pone.0310474. eCollection 2025.
4
Attitudes Toward General Vaccination Mediate the Association Between Influenza Vaccination History and Pneumococcal Vaccination Intention Among Older Adults in China.在中国老年人中,对常规疫苗接种的态度介导了流感疫苗接种史与肺炎球菌疫苗接种意愿之间的关联。
Vaccines (Basel). 2024 Dec 29;13(1):20. doi: 10.3390/vaccines13010020.
5
Immunogenicity and Safety of an Inactivated Quadrivalent Influenza Vaccine Administered Concomitantly with a 23-Valent Pneumococcal Polysaccharide Vaccine in Adults Aged 60 Years and Older.60岁及以上成年人中,四价流感灭活疫苗与23价肺炎球菌多糖疫苗同时接种的免疫原性和安全性
Vaccines (Basel). 2024 Aug 22;12(8):935. doi: 10.3390/vaccines12080935.
6
Addressing Unmet Needs in Vaccination for Older Adults in the Asia Pacific: Insights from the COVID-19 Pandemic.解决亚太地区老年人疫苗接种未满足需求:从 COVID-19 大流行中获得的见解。
Clin Interv Aging. 2023 May 31;18:869-880. doi: 10.2147/CIA.S406601. eCollection 2023.
7
Optimization of Elderly Influenza and Pneumococcal Immunization Programs in Beijing, China Using Health Economic Evaluations: A Modeling Study.利用卫生经济评估优化中国北京老年人流感和肺炎球菌免疫规划:一项建模研究
Vaccines (Basel). 2023 Jan 11;11(1):161. doi: 10.3390/vaccines11010161.
8
A Malaysian consensus recommendation for the prevention of influenza in older persons.马来西亚老年人流感预防共识建议。
BMC Infect Dis. 2022 Dec 15;22(1):943. doi: 10.1186/s12879-022-07920-3.
9
A narrative review on vaccination rate and factors associated with the willingness to receive pneumococcal vaccine in Chinese adult population.关于中国成人人群疫苗接种率和与接种肺炎球菌疫苗意愿相关因素的叙述性综述。
Hum Vaccin Immunother. 2022 Nov 30;18(6):2139123. doi: 10.1080/21645515.2022.2139123. Epub 2022 Nov 15.
10
Influenza Vaccination Coverage among Older Adults with Hypertension in Shenzhen, China: A Cross-Sectional Survey during the COVID-19 Pandemic.中国深圳老年高血压患者的流感疫苗接种率:COVID-19大流行期间的横断面调查
Vaccines (Basel). 2021 Sep 29;9(10):1105. doi: 10.3390/vaccines9101105.

本文引用的文献

1
Overview of influenza vaccination policy in Beijing, China: Current status and future prospects.中国北京市流感疫苗接种政策概述:现状与未来展望。
J Public Health Policy. 2017 Aug;38(3):366-379. doi: 10.1057/s41271-017-0079-7.
2
Cost-effectiveness of a 23-valent pneumococcal polysaccharide vaccine immunization programme for the elderly in Shanghai, China.中国上海针对老年人的23价肺炎球菌多糖疫苗免疫计划的成本效益
Vaccine. 2016 Dec 7;34(50):6158-6165. doi: 10.1016/j.vaccine.2016.11.003. Epub 2016 Nov 9.
3
Seasonal influenza vaccination in China: Landscape of diverse regional reimbursement policy, and budget impact analysis.中国的季节性流感疫苗接种:不同地区报销政策概况及预算影响分析
Vaccine. 2016 Nov 11;34(47):5724-5735. doi: 10.1016/j.vaccine.2016.10.013. Epub 2016 Oct 13.
4
Comparison of dual influenza and pneumococcal polysaccharide vaccination with influenza vaccination alone for preventing pneumonia and reducing mortality among the elderly: A meta-analysis.比较流感和肺炎球菌多糖联合疫苗与单独流感疫苗预防老年人肺炎和降低死亡率的效果:一项荟萃分析。
Hum Vaccin Immunother. 2016 Dec;12(12):3056-3064. doi: 10.1080/21645515.2016.1221552. Epub 2016 Sep 14.
5
Pneumococcal Vaccination Strategies. An Update and Perspective.肺炎球菌疫苗接种策略。最新进展与展望。
Ann Am Thorac Soc. 2016 Jun;13(6):933-44. doi: 10.1513/AnnalsATS.201511-778FR.
6
Australian and New Zealand Society for Geriatric Medicine Position Statement--Immunisation of older people.澳大利亚和新西兰老年医学协会立场声明——老年人免疫接种
Australas J Ageing. 2016 Mar;35(1):67-73. doi: 10.1111/ajag.12213.
7
Pneumococcal Disease Prevention Among Adults: Strategies for the Use of Pneumococcal Vaccines.成人肺炎球菌疾病的预防:肺炎球菌疫苗的使用策略
Am J Prev Med. 2015 Dec;49(6 Suppl 4):S383-90. doi: 10.1016/j.amepre.2015.09.008.
8
The economic burden of influenza-associated outpatient visits and hospitalizations in China: a retrospective survey.中国流感相关门诊就诊和住院的经济负担:一项回顾性调查。
Infect Dis Poverty. 2015 Oct 6;4:44. doi: 10.1186/s40249-015-0077-6.
9
Intervals Between PCV13 and PPSV23 Vaccines: Recommendations of the Advisory Committee on Immunization Practices (ACIP).PCV13 与 PPSV23 疫苗接种间隔:免疫实践咨询委员会(ACIP)的建议。
MMWR Morb Mortal Wkly Rep. 2015 Sep 4;64(34):944-7. doi: 10.15585/mmwr.mm6434a4.
10
Immunogenicity and safety of the 13-valent pneumococcal conjugate vaccine compared to the 23-valent pneumococcal polysaccharide vaccine in elderly Japanese adults.在日本老年成年人中,13价肺炎球菌结合疫苗与23价肺炎球菌多糖疫苗相比的免疫原性和安全性。
Hum Vaccin Immunother. 2015;11(9):2198-206. doi: 10.1080/21645515.2015.1030550. Epub 2015 Jul 15.